| Dr Chudy Nathaniel Okoye, | |
|
1203 Voeglin Ave, Selma, AL 36703-4322 | |
| (334) 875-1478 | |
| (334) 875-1479 |
| Full Name | Dr Chudy Nathaniel Okoye |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Location | 1203 Voeglin Ave, Selma, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922032226 | NPI | - | NPPES |
| 000051145 | Medicaid | AL | |
| 51051145 | Other | AL | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | AL7286 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Chudy Nathaniel Okoye, 1203 Voeglin Ave, Selma, AL 36703-4322 Ph: (334) 875-1478 | Dr Chudy Nathaniel Okoye, 1203 Voeglin Ave, Selma, AL 36703-4322 Ph: (334) 875-1478 |
News Archive
The health care reform law passed last year requires insurers to offer, at a minimum, a set of "essential" benefits to individuals and small groups. ... On Friday, however, the Department of Health and Human Services put out a bulletin proposing to let each state come up with its own definition.
In a new study from the University of Montreal, infants remained calm twice as long when listening to a song, which they didn't even know, as they did when listening to speech. "Many studies have looked at how singing and speech affect infants' attention, but we wanted to know how they affect a baby's emotional self-control," explained Professor Isabelle Peretz, of the university's Center for Research on Brain, Music and Language.
In the largest study of its kind, Feinstein Institutes for Medical Research and Northwell COVID-19 Research Consortium researchers reveal blood clot risk and anticoagulation benefits in hospitalized coronavirus disease 2019 (COVID-19) patients who have been recently discharged from the hospital.
Forest Laboratories announced today its agreement to acquire additional rights to NXL 104, which amends the terms of its prior agreement with Novexel covering the combination of NXL 104 with ceftaroline and adds additional rights to the combination of ceftazidime and NXL 104, through a transaction with AstraZeneca executed immediately following AstraZeneca's announced acquisition of Novexel, S.A.
A team of Medical University of South Carolina Hollings Cancer Center researchers received a three-year, $1.2 million grant from the U.S. Department of Defens to test a potential therapeutic antibody that could block breast cancer growth with fewer side effects, opening up potential for future drug development.
› Verified 2 days ago
Dr. William Scott Walters, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 1015 Medical Center Pkwy, Selma, AL 36701 Phone: 251-342-5646 |